Kewaunee Scientific (NASDAQ:KEQU) Stock, Quote.Headers.trade-ideas

Kewaunee Scientific

Kewaunee Scientific Corp is engaged in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The company operates through two segments: Domestic and International. The Domestic business segment designs manufacture and install scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, work surfaces, workstations, workbenches, and computer enclosures. The International business segment provides facility design, engineering, construction and project management from the planning stage through the testing and commissioning of laboratories. The company generates a majority of its revenue from the Domestic business segment.

Long Ideas

News

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

GTLS

KEQU

OOMA

Although U.S. stocks closed mostly higher on Friday, there were a few notable insider trades.

Insiders Buying Chart Industries And 2 Other Stocks

Penny Stocks

Small Cap

Intraday Update

Movers

AAMC

ABBV

ASLE

BASE

BETS

BNED

CERE

CHWY

ENGN

FRSX

FTEL

GOOGL

HPCO

IESC

INGN

JBLU

LILM

LQDT

MLGO

NAPA

NKLA

NOGN

OLLI

PHIO

PHUN

RCAT

SATL

SEAT

SLDB

SMTC

SPWH

SVFD

SYTA

TRKA

VEEV

VRNT

ZVSA

Shares of Methode Electronics, Inc (NYSE: MEI) fell sharply during Thursday’s session following weak quarterly earnings.

Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

ADSE

ADTX

AEMD

AEZS

AGRX

ALNA

ALRN

AMRN

ANGN

APLT

ASPN

ATXI

AUID

AXDX

AYTU

BDSX

BORR

BPTS

CANF

CDAK

CELU

CNTB

COMS

CULP

CYCC

DRMA

ENDP

ENJY

ENOB

ENSC

EVFM

EZFL

FEMY

FSRD

FWBI

GROV

HIPO

HTCR

HYPR

ICVX

IMNM

KERN

LIDR

LXRX

MARK

MREO

NCTY

NLIT

NMTR

NRSN

NXTP

PETV

PHAR

REVB

RIBT

RNLX

RPID

SMPL

SSIC

TALS

TKLF

TOUR

TYDE

VLCN

VRCA

XCUR

Gainers


	Revelation Biosciences, Inc.  (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.


Akerna Shares Dip 53%, Here&#39;s 78 Biggest Movers From Yesterday

Kewaunee Scientific Corporation - Common Stock

Kewaunee Scientific Corp

Earnings

Kewaunee Scientific Q1 Sales $48.39M Down From $49.84M YoY

WIIM

Kewaunee Scientific shares are trading higher following q4 earnings.

Kewaunee Scientific Q4 Adj EPS $1.55 Up From $0.34 YoY

Kewaunee Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KEQU#NASDAQ">KEQU</a>) reported quarterly earnings of $3.71 per share. This is a 991.18 percent increase over earnings of $0.34 per share from the same period last year. The company reported $56.70 million in sales this quarter. This is a 5.03 percent increase over sales of $53.99 million the same period last year.

Kewaunee Scientific Q4 EPS $3.71 Up From $0.34 YoY, Sales $56.70M Up From $53.99M YoY

Kewaunee Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KEQU#NASDAQ">KEQU</a>) reported quarterly earnings of $0.85 per share. This is a 240 percent increase over earnings of $0.25 per share from the same period last year. The company reported $46.78 million in sales this quarter. This is a 23.09 percent decrease over sales of $60.82 million the same period last year.

Kewaunee Scientific Q3 EPS $0.85 Up From $0.25 YoY, Sales $46.78M Down From $60.82M YoY

<h3>Companies Reporting Before The Bell</h3>
&bull; CTS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTS#NYSE">CTS</a>) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
&bull; Foot Locker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) is likely to report quarterly earnings at $0.32 per share on revenue of $2.28 billion.
&bull; JD.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) is likely to report quarterly earnings at $0.63 per share on revenue of $42.16 billion.
&bull; Super Group (SGHC) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGHC#NYSE">SGHC</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $326.63 million.
&bull; Sotherly Hotels (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOHO#NASDAQ">SOHO</a>) is projected to report earnings for its fourth quarter.
&bull; Thor Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THO#NYSE">THO</a>) is estimated to report quarterly earnings at $0.67 per share on revenue of $2.27 billion.
&bull; Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) is expected to report quarterly earnings at $0.10 per share on revenue of $86.80 million.
&bull; VersaBank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VBNK#NASDAQ">VBNK</a>) is likely to report quarterly earnings at $0.35 per share on revenue of $22.43 million.
&bull; Abercrombie &amp; Fitch (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) is expected to report quarterly earnings at $2.83 per share on revenue of $1.43 billion.
&bull; Brown Forman Inc Class B Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) is expected to report quarterly earnings at $0.56 per share on revenue of $1.12 billion.
&bull; WAVE Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WVE#NASDAQ">WVE</a>) is likely to report quarterly loss at $0.23 per share on revenue of $19.86 million.
&bull; Yatsen Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YSG#NYSE">YSG</a>) is projected to report earnings for its fourth quarter.
&bull; iShares $ Short Duration Corp Bond UCITS ETF USD (Dist) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDIG#NASDAQ">SDIG</a>) is projected to report quarterly loss at $0.98 per share on revenue of $22.21 million.
&bull; InspireMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSPR#NASDAQ">NSPR</a>) is expected to report quarterly loss at $0.19 per share on revenue of $1.63 million.
&bull; Korn Ferry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFY#NYSE">KFY</a>) is estimated to report quarterly earnings at $0.99 per share on revenue of $658.50 million.
&bull; Kamada (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KMDA#NASDAQ">KMDA</a>) is projected to report quarterly earnings at $0.05 per share on revenue of $37.71 million.
&bull; PureCycle Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) is projected to report quarterly loss at $0.23 per share on revenue of $180 thousand.
&bull; Xeris Biopharma Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XERS#NASDAQ">XERS</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $43.55 million.
&bull; Genius Sports (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GENI#NYSE">GENI</a>) is expected to report quarterly loss at $0.07 per share on revenue of $126.13 million.
&bull; Adaptimmune Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAP#NASDAQ">ADAP</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $20.47 million.
&bull; NeueHealth (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEUE#NYSE">NEUE</a>) is estimated to report quarterly loss at $4.16 per share on revenue of $283.44 million.
&bull; Campbell Soup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NYSE">CPB</a>) is projected to report quarterly earnings at $0.77 per share on revenue of $2.44 billion.
&bull; EVgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGO#NASDAQ">EVGO</a>) is projected to report quarterly loss at $0.18 per share on revenue of $44.03 million.
&bull; Hippo Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIPO#NYSE">HIPO</a>) is estimated to report quarterly loss at $2.01 per share on revenue of $55.25 million.
&bull; BrainsWay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWAY#NASDAQ">BWAY</a>) is expected to report quarterly loss at $0.01 per share on revenue of $8.42 million.
&bull; Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) is estimated to report quarterly loss at $0.40 per share on revenue of $1.75 million.
&bull; European Wax Center (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWCZ#NASDAQ">EWCZ</a>) is projected to report quarterly earnings at $0.07 per share on revenue of $54.08 million.
&bull; REV Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REVG#NYSE">REVG</a>) is likely to report quarterly earnings at $0.15 per share on revenue of $579.42 million.
&bull; United Natural Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNFI#NYSE">UNFI</a>) is likely to report quarterly loss at $0.01 per share on revenue of $7.87 billion.
&bull; Berry Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRY#NASDAQ">BRY</a>) is projected to report quarterly earnings at $0.24 per share on revenue of $182.37 million.
&bull; Brown Forman Inc Class A Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) is estimated to report earnings for its third quarter.
&bull; Trinity Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIN#NASDAQ">TRIN</a>) is estimated to report quarterly earnings at $0.54 per share on revenue of $46.42 million.
&bull; Antero Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AR#NYSE">AR</a>) is expected to report earnings for its fourth quarter.
<h3>Companies Reporting After The Bell</h3>
&bull; Descartes Systems Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSGX#NASDAQ">DSGX</a>) is likely to report quarterly earnings at $0.37 per share on revenue of $144.29 million.
&bull; Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) is estimated to report quarterly loss at $0.19 per share on revenue of $293.53 million.
&bull; Fortuna Silver Mines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSM#NYSE">FSM</a>) is estimated to report quarterly earnings at $0.10 per share on revenue of $261.00 million.
&bull; Inovio Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) is estimated to report quarterly loss at $1.27 per share on revenue of $340 thousand.
&bull; Companhia Siderurgica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SID#NYSE">SID</a>) is likely to report quarterly earnings at $0.19 per share on revenue of $2.32 billion.
&bull; Global X Silver Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIL#NYSE">SIL</a>) is expected to report quarterly earnings at $0.10 per share on revenue of $44.09 million.
&bull; TDCX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDCX#NYSE">TDCX</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $121.92 million.
&bull; Vermilion Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VET#NYSE">VET</a>) is expected to report quarterly earnings at $0.52 per share on revenue of $440.69 million.
&bull; VSE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSEC#NASDAQ">VSEC</a>) is expected to report quarterly earnings at $0.75 per share on revenue of $234.91 million.
&bull; Victoria&#39;s Secret (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) is projected to report quarterly earnings at $2.47 per share on revenue of $2.09 billion.
&bull; SandRidge Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SD#NYSE">SD</a>) is likely to report earnings for its fourth quarter.
&bull; CPS Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPSH#NASDAQ">CPSH</a>) is projected to report earnings for its fourth quarter.
&bull; Grove Collaborative Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GROV#NYSE">GROV</a>) is expected to report quarterly loss at $0.23 per share on revenue of $61.45 million.
&bull; KLX Energy Services Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLXE#NASDAQ">KLXE</a>) is projected to report quarterly earnings at $0.01 per share on revenue of $212.97 million.
&bull; Culp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CULP#NYSE">CULP</a>) is likely to report quarterly loss at $0.16 per share on revenue of $59.49 million.
&bull; GEN Restaurant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENK#NASDAQ">GENK</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $43.95 million.
&bull; MISTRAS Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MG#NYSE">MG</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $174.28 million.
&bull; IDT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDT#NYSE">IDT</a>) is projected to report earnings for its second quarter.
&bull; FRP Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPH#NASDAQ">FRPH</a>) is projected to report earnings for its fourth quarter.
&bull; Global Water Resources (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWRS#NASDAQ">GWRS</a>) is estimated to report quarterly earnings at $0.05 per share on revenue of $12.00 million.
&bull; NeoGames (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGMS#NASDAQ">NGMS</a>) is projected to report quarterly loss at $0.07 per share on revenue of $54.53 million.
&bull; Hamilton Beach Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HBB#NYSE">HBB</a>) is estimated to report earnings for its fourth quarter.
&bull; Amplify Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPY#NYSE">AMPY</a>) is likely to report quarterly earnings at $0.18 per share on revenue of $76.22 million.
&bull; Pampa Energia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAM#NYSE">PAM</a>) is likely to report quarterly loss at $0.09 per share on revenue of $421.19 million.
&bull; Talphera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLPH#NASDAQ">TLPH</a>) is estimated to report quarterly loss at $0.20 per share on revenue of $280 thousand.
&bull; Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) is expected to report quarterly loss at $0.12 per share on revenue of $70 thousand.
&bull; HighPeak Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HPK#NASDAQ">HPK</a>) is expected to report quarterly earnings at $0.65 per share on revenue of $339.52 million.
&bull; BRC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRCC#NYSE">BRCC</a>) is estimated to report quarterly loss at $0.01 per share on revenue of $123.75 million.
&bull; MDxHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXH#NASDAQ">MDXH</a>) is likely to report quarterly loss at $0.11 per share on revenue of $18.14 million.
&bull; NACCO Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NC#NYSE">NC</a>) is estimated to report earnings for its fourth quarter.
&bull; Enhabit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHAB#NYSE">EHAB</a>) is expected to report quarterly earnings at $0.03 per share on revenue of $260.16 million.
&bull; Intrepid Potash (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) is projected to report quarterly loss at $0.06 per share on revenue of $43.57 million.
&bull; OneSpan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSPN#NASDAQ">OSPN</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $58.26 million.
&bull; Honest Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNST#NASDAQ">HNST</a>) is estimated to report quarterly loss at $0.08 per share on revenue of $84.14 million.
&bull; SilverCrest Metals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SILV#AMEX">SILV</a>) is expected to report quarterly earnings at $0.10 per share on revenue of $44.09 million.
&bull; AudioEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEYE#NASDAQ">AEYE</a>) is estimated to report quarterly loss at $0.11 per share on revenue of $7.93 million.
&bull; comScore (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCOR#NASDAQ">SCOR</a>) is likely to report quarterly earnings at $0.20 per share on revenue of $97.69 million.
&bull; Viemed Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMD#NASDAQ">VMD</a>) is projected to report quarterly earnings at $0.10 per share on revenue of $50.00 million.
&bull; Kewaunee Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KEQU#NASDAQ">KEQU</a>) is projected to report earnings for its third quarter.
&bull; ChromaDex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXC#NASDAQ">CDXC</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $20.98 million.
&bull; Whitestone REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSR#NYSE">WSR</a>) is projected to report earnings for its fourth quarter.
&bull; Aris Water Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARIS#NYSE">ARIS</a>) is estimated to report earnings for its fourth quarter.
&bull; OrthoPediatrics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KIDS#NASDAQ">KIDS</a>) is expected to report quarterly loss at $0.28 per share on revenue of $37.73 million.
&bull; Invesco National AMT-Free Municipal Bond ETFo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PZA#NYSE">PZA</a>) is estimated to report earnings for its fourth quarter.
&bull; Hudson Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HDSN#NASDAQ">HDSN</a>) is projected to report quarterly earnings at $0.08 per share on revenue of $40.28 million.
&bull; Stabilis Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNG#NASDAQ">SLNG</a>) is projected to report earnings for its fourth quarter.
&bull; Airgain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRG#NASDAQ">AIRG</a>) is projected to report quarterly loss at $0.20 per share on revenue of $10.00 million.
&bull; Finance of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOA#NYSE">FOA</a>) is projected to report quarterly loss at $0.08 per share on revenue of $63.22 million.
&bull; Yext (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YEXT#NYSE">YEXT</a>) is likely to report quarterly earnings at $0.07 per share on revenue of $100.24 million.
&bull; TriplePoint Venture Gwth (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPVG#NYSE">TPVG</a>) is expected to report quarterly earnings at $0.48 per share on revenue of $33.13 million.
&bull; CompoSecure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPO#NASDAQ">CMPO</a>) is estimated to report quarterly earnings at $0.23 per share on revenue of $96.49 million.
&bull; Kodiak Gas Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGS#NYSE">KGS</a>) is expected to report quarterly earnings at $0.29 per share on revenue of $222.52 million.
&bull; Cyber Hornet S&amp;P 500 and Bitcoin 75/25 Strategy ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZZZ#NASDAQ">ZZZ</a>) is likely to report quarterly earnings at $0.53 per share on revenue of $247.43 million.
&bull; Ellington Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) is projected to report quarterly earnings at $0.23 per share on revenue of $2.46 million.
&bull; Spire Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPIR#NYSE">SPIR</a>) is expected to report quarterly loss at $0.72 per share on revenue of $29.34 million.
&bull; Lulus Fashion Lounge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVLU#NASDAQ">LVLU</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $73.40 million.
&bull; Rush Street Interactive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSI#NYSE">RSI</a>) is likely to report quarterly loss at $0.03 per share on revenue of $178.56 million.
&bull; Hamilton Insurance Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HG#NYSE">HG</a>) is expected to report quarterly earnings at $0.65 per share on revenue of $15.30 million.
&bull; Infinera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFN#NASDAQ">INFN</a>) is likely to report quarterly earnings at $0.09 per share on revenue of $437.34 million.
&bull; Riley Exploration Permian (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/REPX#AMEX">REPX</a>) is estimated to report quarterly earnings at $1.60 per share on revenue of $94.75 million.
&bull; Zymeworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYME#NASDAQ">ZYME</a>) is expected to report quarterly loss at $0.43 per share on revenue of $15.45 million.
&bull; Miller Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLR#NYSE">MLR</a>) is projected to report earnings for its fourth quarter.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

ADAP

AEYE

AIRG

AMPY

ARIS

BRCC

BWAY

CDXC

CMPO

CPSH

DSGX

EARN

EHAB

EVGO

EWCZ

FRPH

GENI

GENK

GWRS

HDSN

HNST

HTOO

INFN

KIDS

KLXE

KMDA

LVLU

MDXH

NEUE

NEXN

NGMS

NSPR

OSPN

PowerShares Insured Municipal Bond Portfolio

REPX

REVG

SCOR

SDIG

SGHC

SILV

SLNG

SOHO

SPIR

TDCX

TLPH

TPVG

TRIN

UNFI

VBNK

VSCO

VSEC

XERS

YEXT

ZYME

Earnings Scheduled For March 6, 2024

Although U.S. stocks closed mostly higher on Friday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#39;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Ooma </h3>
<ul>
<li>The Trade: Ooma, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ooma#NYSE">OOMA</a>) CEO and President Eric B Stang <a href="https://www.benzinga.com/quote/OOMA/analyst-ratings"> acquired a total of 10,000 shares </a> an average price of $9.85. To acquire these shares, it cost around $98,486.</li>
<li>What&rsquo;s Happening: On Dec. 5, Ooma posted in-line earnings for its third quarter.</li>
<li>What Ooma Does: Ooma Inc is a United States-based provider of innovative communication solutions and other connected services to small business, home, and mobile users.</li>
</ul>
<h3>Chart Industries </h3>
<ul>
<li>The Trade: Chart Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gtls#NYSE">GTLS</a>) Director Linda Harty acquired a total of 1,000 shares at an average price of $130.14. To acquire these shares, it cost around $130,140.</li>
<li>What&rsquo;s Happening: On Oct. 27, Chart Industries reported worse-than-expected third-quarter financial results and lowered full year 2023 sales guidance.</li>
<li>What Chart Industries Does: Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas (LNG) industries.</li>
</ul>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
<h3>Kewaunee Scientific </h3>
<ul>
<li>The Trade: Kewaunee Scientific Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kequ#NASDAQ">KEQU</a>) Director John Russell <a href="https://www.benzinga.com/sec/insider-trades/"> bought a total of 7,500 shares </a> at an average price of $22.98. To acquire these shares, it cost around $172,361.</li>
<li>What&rsquo;s Happening: On Dec. 6, Kewaunee Scientific posted a profit for the second quarter.</li>
<li>What Kewaunee Scientific Does: Kewaunee Scientific Corp is engaged in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products.</li>
</ul>
&nbsp;
Check This Out: <a href="https://www.benzinga.com/news/earnings/23/12/36276431/heico-emcor-group-and-3-stocks-to-watch-heading-into-monday"> HEICO, EMCOR Group And 3 Stocks To Watch Heading Into Monday </a>

It was revealed in a recent SEC filing that John Russell, Director at Kewaunee Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KEQU#NASDAQ">KEQU</a>) made a noteworthy insider purchase on December 15,.
What Happened: Russell's recent purchase of 7,500 shares of Kewaunee Scientific, disclosed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000055529/000152220923000004//Archives/edgar/data/55529/000152220923000004/0001522209-23-000004-index.htm">U.S. Securities and Exchange Commission</a> on Friday, reflects confidence in the company's potential. The total transaction value is $172,361.
Kewaunee Scientific shares are trading up 0.69% at $23.51 at the time of this writing on Friday morning.
<h3>Delving into Kewaunee Scientific's Background</h3>
Kewaunee Scientific Corp is engaged in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The company operates through two segments: Domestic and International. The Domestic business segment designs manufacture and install scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, work surfaces, workstations, workbenches, and computer enclosures. The International business segment provides facility design, engineering, construction and project management from the planning stage through the testing and commissioning of laboratories. The company generates a majority of its revenue from the Domestic business segment.
<h3>Financial Insights: Kewaunee Scientific</h3>
Negative Revenue Trend: Examining Kewaunee Scientific's financials over 3 months reveals challenges. As of 31 October, 2023, the company experienced a decline of approximately -7.57% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Profitability Metrics: Unlocking Value
<ul>
<li>
Gross Margin: The company shows a low gross margin of 26.7%, indicating concerns regarding cost management and overall profitability relative to its industry counterparts.
</li>
<li>
Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 0.94, Kewaunee Scientific showcases strong earnings per share.
</li>
</ul>
Debt Management: Kewaunee Scientific's debt-to-equity ratio stands notably higher than the industry average, reaching 0.35. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Assessing Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: Kewaunee Scientific's P/E ratio of 9.89 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 0.32, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Indicated by a lower-than-industry-average EV/EBITDA ratio of 4.0, the company suggests a potential undervaluation, which might be advantageous for value-focused investors.
</li>
</ul>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
Investors should view insider transactions as part of a multifaceted analysis and not rely solely on them for decision-making.
From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.
While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.
<h3>Understanding Crucial Transaction Codes</h3>
Examining transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often concentrate on those unfolding in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000055529">Check Out The Full List Of Kewaunee Scientific's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Kewaunee Scientific Director Makes $172K Stock Purchase

Shares of Methode Electronics, Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mei#NYSE">MEI</a>) fell sharply during Thursday&rsquo;s session following <a href="https://www.benzinga.com/quote/MEI/earnings">weak quarterly earnings</a>.
Methode Electronics posted adjusted earnings of 6 cents per share, missing market estimates of 12 cents per share. The company&rsquo;s quarterly sales came in at $288.00 million versus expectations of $292.82 million, according to <a href="https://pro.benzinga.com/">Benzinga Pro.</a>
Methode Electronics shares fell 14.2% to $20.92 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Save Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/svfd#NASDAQ">SVFD</a>) shares climbed 186.7% to $6.16 after the company highlighted targeting of US carbon credit market following acquisition of majority ownership in newly- formed Nitrousink Ltd.</li>
<li>Cyngn Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyn#NASDAQ">CYN</a>) gained 90.4% to $0.4643 after the company announced the issuance of a new patent, US-11,837,089-B2, for the autonomous vehicle (AV) and driving solutions.</li>
<li>Barnes &amp; Noble Education, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bned#NYSE">BNED</a>) shares climbed 31.9% to $1.3850 following upbeat quarterly earnings.</li>
<li>Hempacco Co., Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hpco#NASDAQ">HPCO</a>) shares climbed 28.8% to $0.4331 after the company announced it entered into an exclusive Master Distribution Agreement with CBDAY Global. Under the agreement, CBDAY will exclusively sell Hempacco&#39;s line of hemp and CBD products in India and Thailand.</li>
<li>MicroAlgo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mlgo#NASDAQ">MLGO</a>) shares gained 26% to $12.07. MicroAlgo shares jumped over 295% on Wednesday after the company announced it plans to establish a postgraduate training practice base.</li>
<li>Kewaunee Scientific Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kequ#NASDAQ">KEQU</a>) climbed 25.5% to $22.53 following second-quarter earnings.</li>
<li>Inogen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ingn#NASDAQ">INGN</a>) climbed 23.3% to $6.15.</li>
<li>Satellogic Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/satl#NASDAQ">SATL</a>) rose 22% to $1.9584. Uzma and Satellogic signed a multi-million dollar +3-year agreement to advance geospatial capabilities in Southeast Asia.</li>
<li>Fitell Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ftel#NASDAQ">FTEL</a>) gained 19.7% to $1.70.</li>
<li>Altisource Asset Management Corporation(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aamc#NYSE">AAMC</a>) gained 19.3% to $4.0213. Altisource Asset Management reported key ruling in Blackrock and PIMCO litigation.</li>
<li>Semtech Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smtc#NASDAQ">SMTC</a>) climbed 18.5% to $19.80 after the company reported third-quarter financial results and issued guidance.</li>
<li>Altimmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alt#NASDAQ">ALT</a>) gained 18.3% to $8.14.</li>
<li>Solid Biosciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sldb#NASDAQ">SLDB</a>) gained 17.6% to $4.0250. Solid Biosciences received FDA fast track designation for its SGT-003 duchenne muscular dystrophy gene therapy candidate.</li>
<li>JetBlue Airways Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jblu#NASDAQ">JBLU</a>) climbed 15.8% to $5.48 after the company said that demand for travel remains healthy, with close-in bookings outperforming expectations for both holiday peak and non-holiday travel periods since late October.</li>
<li>Siyata Mobile Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/syta#NASDAQ">SYTA</a>) rose 15.2% to $3.8001 after announcing $900,000 follow-on orders.</li>
<li>Verint Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrnt#NASDAQ">VRNT</a>) gained 14% to $27.40 after the company reported better-than-expected third-quarter financial results and issued guidance.</li>
<li>Lilium N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lilm#NASDAQ">LILM</a>) gained 14% to $1.2650 after the company announced it signed a Memorandum of Understanding with Lufthansa Group for a strategic partnership.</li>
<li>AerSale Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asle#NASDAQ">ASLE</a>) shares surged 13.4% to $16.16 after the company announced the FAA has issued the company a Supplemental Type Certificate for AerAware, its Enhanced Flight Vision System for the Boeing B737NG product line.</li>
<li>Cerevel Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cere#NASDAQ">CERE</a>) gained 12.2% to $41.44 after AbbVie Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/abbv#NYSE">ABBV</a>) announced it will acquire the company for a total equity value of approximately $8.7 billion.</li>
<li>IES Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iesc#NASDAQ">IESC</a>) gained 11.8% to $79.68 following quarterly results.</li>
<li>Couchbase, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/base#NASDAQ">BASE</a>) rose 5.7% to $21.07 as the company reported upbeat results for its third quarter and issued strong revenue outlook for FY24.</li>
<li>Alphabet Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/googl#NASDAQ">GOOGL</a>) gained 5.1% to $136.62. Google made a significant announcement, launching Gemini AI, its most powerful AI model to date.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Troika Media Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trka#NASDAQ">TRKA</a>) shares fell 74.8% to $0.4812 after the company announced it filed for Chapter 11.</li>
<li>Phio Pharmaceuticals Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phio#NASDAQ">PHIO</a>) shares dipped 40% to $0.9462 as the company announced exercise of warrants for $2.8 million gross proceeds.</li>
<li>Bit Brother Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bets#NASDAQ">BETS</a>) fell 38.8% to $0.0214. Bit Brother recently announced the pricing of a $12 million registered direct offering.</li>
<li>FLJ Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flj#NASDAQ">FLJ</a>) fell 36% to $2.91.</li>
<li>ZyVersa Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zvsa#NASDAQ">ZVSA</a>) shares tumbled 35.4% to $1.3789 after the company priced its $5 million public offering.</li>
<li>Foresight Autonomous Holdings Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frsx#NASDAQ">FRSX</a>) fell 32.8% to $1.25 as the company announced pricing of $4.5 million registered direct offering.</li>
<li>Red Cat Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rcat#NASDAQ">RCAT</a>) shares fell 30.5% to $0.5280. Red Cat priced public offering of 16 million common shares at $0.50 per share for gross proceeds of $8 million.</li>
<li>Sprinklr, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cxm#NYSE">CXM</a>) shares fell 29.4% to $11.76 following weak earnings for the third quarter.</li>
<li>Wave Life Sciences Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wve#NASDAQ">WVE</a>) shares fell 29.1% to $4.87 after the company priced its $100 million public offering of ordinary shares.</li>
<li>Nogin, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nogn#NASDAQ">NOGN</a>) fell 26.3% to $0.1334 after the company entered Chapter 11 bankruptcy proceedings in combination with a stalking horse bid and Debtor in Possession financing provided by B. Riley Financial, Inc.</li>
<li>enGene Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/engn#NASDAQ">ENGN</a>) declined 23.8% to $7.87.</li>
<li>Sportsman&#39;s Warehouse Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spwh#NASDAQ">SPWH</a>) fell 21.4% to $4.18. Sportsman&#39;s Warehouse said it sees fourth-quarter loss of 35 cents to 25 cents per share.</li>
<li>Phunware, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phun#NASDAQ">PHUN</a>) fell 19% to $0.1030 as the company reported pricing of $2.8 million public offering.</li>
<li>Nikola Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nkla#NASDAQ">NKLA</a>) fell 18.1% to $0.8047 after the company announced proposed offerings of common stock and convertible senior notes.</li>
<li>BAIYU Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/byu#NASDAQ">BYU</a>) shares fell 17.7% to $1.49.</li>
<li>Vivid Seats Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seat#NASDAQ">SEAT</a>) declined 15.6% to $6.87. Vivid Seats announced secondary offering of 18.5 million class A common stock.</li>
<li>Argan, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/agx#NYSE">AGX</a>) fell 13.1% to $41.50 following downbeat earnings.</li>
<li>Liquidity Services, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lqdt#NASDAQ">LQDT</a>) dipped 12.8% to $17.36 following weak sales.</li>
<li>The Duckhorn Portfolio, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/napa#NYSE">NAPA</a>) fell 10.7% to $9.11 following downbeat quarterly results.</li>
<li>C3.ai, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ai#NYSE">AI</a>) shares fell 9.8% to $26.30 after the company reported mixed second-quarter financial results and issued guidance.</li>
<li>Chewy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chwy#NYSE">CHWY</a>) fell 6% to $18.18 after the company reported mixed third-quarter financial results and cut FY23 net sales guidance.</li>
<li>Ollie&#39;s Bargain Outlet Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/olli#NASDAQ">OLLI</a>) declined 5.5% to $72.09.</li>
<li>Greif, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gef#NYSE">GEF</a>) declined 5.5% to $65.83 following weak sales.</li>
<li>Veeva Systems Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/veev#NYSE">VEEV</a>) shares fell 4.1% to $171.20 after the company reported third-quarter financial results and issued guidance.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/12/36127763/i-like-it-very-much-jim-cramer-bullish-on-this-financial-stock-up-75-ytd"> &#39;I Like It Very Much&#39;: Jim Cramer Bullish On This Financial Stock Up 75% YTD</a>

Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Yield10 Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YTEN#NASDAQ">YTEN</a>) shares rose 104.4% to $0.46 during Thursday's regular session. The market value of their outstanding shares is at $5.4 million. </li>
<li>Solid Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDB#NASDAQ">SLDB</a>) stock rose 54.67% to $5.29. The market value of their outstanding shares is at $106.7 million. </li>
<li>Kewaunee Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KEQU#NASDAQ">KEQU</a>) stock increased by 29.89% to $22.9. The market value of their outstanding shares is at $66.5 million. As per the press release, Q2 earnings came out yesterday. </li>
<li>G1 Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTHX#NASDAQ">GTHX</a>) stock increased by 22.1% to $2.96. The company's market cap stands at $153.1 million. </li>
<li>Know Labs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KNW#AMEX">KNW</a>) shares rose 19.55% to $0.56. The company's market cap stands at $44.8 million. </li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) shares rose 19.13% to $1.37. The company's market cap stands at $4.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Phio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) shares declined by 40.3% to $0.95 during Thursday's regular session. The market value of their outstanding shares is at $2.3 million. </li>
<li>WAVE Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WVE#NASDAQ">WVE</a>) stock fell 30.21% to $4.79. The market value of their outstanding shares is at $474.9 million. </li>
<li>Kineta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KA#NASDAQ">KA</a>) stock decreased by 27.8% to $3.17. The market value of their outstanding shares is at $32.9 million. </li>
<li>Kintara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTRA#NASDAQ">KTRA</a>) stock decreased by 18.64% to $0.23. </li>
<li>Brainstorm Cell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCLI#NASDAQ">BCLI</a>) stock declined by 17.6% to $0.24. The market value of their outstanding shares is at $12.0 million. </li>
<li>Concord Medical Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) stock fell 16.54% to $0.93. The company's market cap stands at $40.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

Kewaunee Scientific

Kewaunee Scientific (KEQU) Forecast

Kewaunee Scientific (NASDAQ:KEQU) Stock, Quote.Headers.trade-ideas